Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oligodendrocyte Progenitor Cell Differentiation (OPC Differentiation)
- Target
- OPC Differentiation
- Molecular classification
- Cellular Differentiation Process, Developmental Biology, Cell Fate Determination
01
Overview
Oligodendrocyte progenitor cell (OPC) differentiation refers to the process by which OPCs mature into myelinating oligodendrocytes, a critical step for proper central nervous system (CNS) function. Mature oligodendrocytes are responsible for forming the myelin sheath that insulates neuronal axons and enables rapid signal transmission. The process involves several stages: proliferation, lineage commitment, premyelinating stage and maturation. Key molecular regulators include transcription factors (OLIG1, OLIG2, SOX10, NKX2.2), chromatin modifiers & miRNAs, extracellular matrix components, and integrins. Proper regulation of this pathway is vital for CNS health; defects lead to demyelinating diseases such as multiple sclerosis. Enhancing endogenous or transplanted OPC differentiation holds therapeutic promise for remyelination strategies after injury or disease.
- Other names
- OPC MaturationOligodendrocyte Lineage ProgressionMyelinating Oligodendrocyte Development
02
Biological functions
MyelinationAxonal InsulationCNS DevelopmentRemyelinationGlial Cell Differentiation
03
Disease associations
Multiple SclerosisDemyelinating DiseasesCNS InjuryNeurodegenerative Diseases
04
Safety considerations
Aberrant differentiation leading to tumor formationOff-target effects of differentiation-inducing agentsUncontrolled myelination
05
Biomarkers
NG2 (CSPG4)PDGFRAO4Sox10GalCMBP (myelin basic protein)PLP1 (proteolipid protein 1)MAG (myelin-associated glycoprotein)
Beyond the preview
Go deeper on Oligodendrocyte Progenitor Cell Differentiation (OPC Differentiation).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oligodendrocyte Progenitor Cell Differentiation (OPC Differentiation).